Systematic (IUPAC) name | |
---|---|
N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 329016-45-7 |
ATC code | ? |
PubChem | CID 9820874 |
Chemical data | |
Formula | C20H24FN3O3 |
Mol. mass | 373.421 g/mol |
SMILES | eMolecules & PubChem |
(verify) |
(what is this?)
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABAA receptors, and was developed by Pfizer as a potential anxiolytic, however poor blood-brain barrier penetration make it primarily useful as a research ligand.[1][2]